STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 55 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $71,000 | +14.5% | 25,659 | +0.3% | 0.00% | – |
| Q4 2020 | $62,000 | +37.8% | 25,591 | +20.5% | 0.00% | – |
| Q3 2020 | $45,000 | -45.1% | 21,239 | -2.2% | 0.00% | – |
| Q2 2020 | $82,000 | +105.0% | 21,721 | +1.4% | 0.00% | – |
| Q1 2020 | $40,000 | -14.9% | 21,424 | -5.5% | 0.00% | – |
| Q4 2019 | $47,000 | -14.5% | 22,662 | -0.8% | 0.00% | – |
| Q3 2019 | $55,000 | -23.6% | 22,853 | -0.7% | 0.00% | – |
| Q2 2019 | $72,000 | -54.7% | 23,012 | +28.5% | 0.00% | -100.0% |
| Q1 2018 | $159,000 | +31.4% | 17,911 | +7.6% | 0.00% | – |
| Q4 2017 | $121,000 | +19.8% | 16,640 | +13.2% | 0.00% | – |
| Q3 2017 | $101,000 | +4.1% | 14,697 | +8.1% | 0.00% | – |
| Q2 2017 | $97,000 | – | 13,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |